Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02019 DEXIN CHINA
RTNominal unchange0.085 0.000 (0.000%)
Research Report

17/02/2021 11:12

CMBIS starts Dexin China (02019) at "buy" and HK$3.56

[ET Net News Agency, 17 February 2021] CMB International Securities (CMBIS) initiated
coverage on Dexin China (02019) with a "buy" rating and a target price of HK$3.56.
As a key Hangzhou player (32% of its land bank), Dexin has seized the booming local
demand to expand into Yangtze Delta/national Tier 2 cities and achieved 25% attributable
sales CAGR in 2018-20 to RMB21.8bn, said the research house.
With an abundant and quality land bank, Dexin can continue to deliver 15-20%
attributable sales growth in 2020-22, CMBIS noted. This growing scale would help Dexin to
increase the attributable/consolidated sales ratio (35%/45% in 2020) to boost national
brand influences and balance sheet transparency.
It also expects Dexin's core earnings to grow at 6% CAGR in 2019-22. (KL)

Back to Research Report

Remark: Real time quote last updated: 19/09/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.